One (1.9%) developed asymmetric hypertrophy (HCM), mild mitral valve prolapse (MVP) and mild ascending aortic dilatation; additional genetic tests identified a variant of unknown significance in TPM1 and KCNQ1 genes. This evidence concerns the gene TPM1 and Ascending tubular aorta aneurysm.